Novel strategic innovations for designing drug delivery system using molecularly imprinted micro/nanobeads

International Journal of Pharmaceutical Sciences Review and Research

Volumn 20, Issue 2, 2013, Pages 235-268

  Suedee, Roongnapa ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Cancer drug delivery; Controlled release; Molecular imprinting; Nanotechnology; Self assembly

Indexed keywords

DOXORUBICIN; GEMCITABINE; MOLECULARLY IMPRINTED POLYMER; NANOBEAD; PROPRANOLOL;

BINDING SITE; BIODEGRADABILITY; BIOMIMETICS; BLOOD BRAIN BARRIER; CANCER THERAPY; DRUG CONFORMATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG SYNTHESIS; ENTROPY; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; MACROMOLECULE; MICROTUBULE ASSEMBLY; MOLECULAR IMPRINTING; MOLECULAR RECOGNITION; MORTALITY; NONHUMAN; PARTICLE SIZE; PHAGOCYTE; POLYMERIZATION; PROCESS DESIGN; PROCESS OPTIMIZATION; RETICULOENDOTHELIAL SYSTEM; REVIEW; STEREOCHEMISTRY; STOICHIOMETRY; THERMODYNAMICS;

EID: 84878864082     PISSN: 0976044X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (123)

1. Greish K., Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines, J. Drug Target, 15(7-8), 2007, 457-464.
2. Owens D. E., Peppas N. A., Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles, Int. J. Pharm., 307, 2006, 93-102.
3. van Vlerken L., Vyas T., Amiji M., Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery, Pharm. Res., 24(8), 2007, 1405-1414.
4. Dass C. R., Drug delivery in cancer using liposomes, Methods Mol. Bio., 437, 2008, 177-182.
5. Li C., Wallace S., Polymer-drug conjugates: Recent development in clinical oncology, Adv. Drug Deliv. Rev., 60(8), 2008, 886-898.
6. Peer D., Karp J. M., Hong S., Farokhzad O. C., Margalit R., Langer R., Nanocarriers as an emerging platform for cancer therapy, Nat. Nano, 2(12), 2007, 751-760.
7. Torchilin V. P., Targeted pharmaceutical nanocarriers for cancer therapy and imaging, AAPSJournal, 9(2), 2007, E128-E147.
8. Yokoyama M., Drug targeting with nano-sized carrier system, J. Artif. Organs, 8(2), 2005, 77-84.
9. Liechty W. B., Kryscio D. R., Slaughter B. V., Peppas N. A., Polymer for DDSs, Ann. Rev. Chem. Biomol. Engineer, 1, 2010, 149-173.
10. Byrne M. E., Salian V., Molecular imprinting within hydrogels II: Progress and analysis of the field, Int. J. Pharm., 364, 2008, 188-212.
11. Lownan A. M., Peppas N. A., In: Encyclopaedia of controlled drug delivery, vol 2, Mathowitz E., ed, New York, John Wiley &Sons, 1999, 397-418.
12. Nishiyama N., Kataoka K., Current state, achievements, and future prospects of micelles as nanocarriers for drug and gene delivery, Pharmacol. Ther., 112(3), 2006, 630-648.
13. Laakkonen P., Vuorinen K., Homing peptides as targeted delivery vehicles, Integr. Biology, 2, 2010, 326-337.
14. Park K., Mrsny R. J., Controlled drug delivery: present and future, ACSSymposium Series, vol 752, Chapter 1, 2000, 2-12.
15. Mitragotri S., Lahann J., Controlled drug delivery: present and future, Nature Materials, 8, 2009, 15-23.
16. Nasongkla N., Chen B., Macaraeg N., Fox M. E., Fréchet J. M., Szoka F. C., Dependence of pharmacokinetics and biodistribution on polymer architecture: Effect of cyclic versus linear polymers, GPC, Biopolymer, J. Am. Chem. Soc., 13, 2009a, 3842-3843.
17. Nasongkla N., Akarajiratun P., Hongeng S., Development of tri-component copolymer rods as implantable DDSs for liver cancer therapy, In: The 2009 World Congress on Medical Physics and Biomedical Engineering, Springerlink, Munich, Germany, IFMBE Proceedings 2508, 2009b, 317-320.
18. Nasongkla N., Bey E., Ren J., Ai H., Khemtong C., Guthi J. S., Chin S. F., Sherry A. D., Boothman D. A., Gao J., Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive DDS, Nano Lett., 6, 2006, 2427-2430.
19. Bae Y., Fukushima S., Harada A., Kataoka K., Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change, Angew. Chem. Int. Ed., 42, 2003, 4640-4643.
20. Bae Y., Nishiyama N., Fukushima S., Koyama H., Yasuhiro M., Kataoka K., Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy, Bioconjug. Chem., 16, 2005, 122-130.
21. Bae Y., Nishiyama N., Kataoka K., In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments, Bioconjug. Chem., 18, 2007, 1131-1139.
22. Meyer D. E., Shin B. C., Kong G. A., Dewhirst M. W., Chilikot A., Drug targeting using thermally using responsive polymers and local hyperthermia, J. Control. Release, 74(1-3), 2001, 213-224.
23. Lee I. H., Yu M. K., Kim I. H., Lee J. -H., Park T. G., Jon S., A duplex oligodeoxynucleotide-dendrimer bioconjugate as a novel delivery vehicle for doxorubicin in vivo cancer therapy, J. Control. Release, 155(1), 2011, 88-95.
24. Patel M. P., Patel R. R., Patel J. K., Chitosan mediated targeted DDS: A review, J. Pharm. Pharmaceut. Sci., 13(3), 2010, 536-557.
25. Janes K. A., Calvo P., Alonso M. J., Polysaccharide colloidal particles as drug delivery for macromolecule, Adv. Drug Deliv. Rev., 47(1), 2001, 83-97.
26. Yang W., Fu J., Wang T., He N., Chitosan/sodium tripolyphosphate nanoparticles: preparation characterization and application as drug carrier, J. Biomed. Nanotechnol., 5(5), 2009, 591-595.
27. Wei W., Yue Z. G., Qu J. B., Yue H., Su Z. G., Ma G., Galactosylated nanocrystallites of insoluble anticancer drug for liver-targeting therapy: an in vitro evaluation Nanomedicine, 5(4), 2010, 589-596.
28. Weitman S. D., Lark R. H., Coney L. R., Fort D. W., Frasca V., Zurawski Jr. V. R., Kamen B. A., Distribution of the folate receptor GP38 in normal and malignant-cell lines and tissues, Cancer Res., 52(12), 1992, 3396-3401.
29. Peng X-H., Qian X., Mao H., Wang A. Y., Chen Z., Nie S., Shin D. M., Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy, Int. J. Nanomedicine, 3(3), 2008, 311-321.
30. Lammers T., Subr V., Ulbrich K., Peschke P., Huber P. E., Hennink W. E., Strom G., Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers, Biomaterials, 30, 2009, 3466-3477.
31. Alexander C., Andersson H. S., Andersson L. I., Ansell R. J., Kirsch N., Nicholls I. A., O'Mahony J., Whitcombe M. J., Molecular imprintingscience and technology: a survey of the literature for the years up to and including 2003, J. Mol. Recognit., 19, 2006, 106-180.
32. Dickey F. H., The preparation of specific adsorbants, Proc. Natl. Acad. Sci. USA, 35(5), 1949, 227-229.
33. Wulff G., Biffis A., Molecular imprinting with covalent or stoichiometric non-covalent interactions, MIPs In: Man made mimics of antibodies and their application in analytical chemistry, Sellergren B., ed, Elsevier Science BV, Amsterdam, 2001, 71-111.
34. Norell M. C., Andersson H. S., Nicholls I. A., Theophylline MIP dissociation kinetics: a novel sustained release drug dosage form mechanism, J. Mol. Recognit., 11, 1998, 98-102.
35. Wulff G., Sarhan A., Über die anwendung von enzymanalog gebauten polymeren zur racemattrennung, Angew. Chem., 84, 1972, 364.
36. Arshady R., Mosbach K., Synthesis of substrate-selective polymers by host-guest polymerization, Macromol. Chem. Phys., 182, 1981, 687-692.
37. Mosbach K., Ramström O., The emerging technique of molecular imprinting and its future impact on biotechnology, Biotechnology, 14, 1996, 163-170.
38. Sellergren B., The non-covalent approach to molecular imprinting, In: MIPs: Man made mimics of antibodies and their application in analytical chemistry, Sellergren B., ed, Elsevier Science BV, Amsterdam, 2001, 113-184.
39. Dickert F. L., Keppler M., Self-organized phases combined with IDC devices-switchable materials for solvent vapor detection, Adv. Mat., 7(12), 1995, 1020-1023.
40. Sellergren B., Allender C. J., MIPs: A bridge to advanced drug delivery, Adv. Drug Deliv. Rev., 57, 2005, 1733-1741.
41. Biffis A., Dyorakova G., Falcimaigne-Cordin A., Physical forms of MIPs, In: Topics in current chemistry, Chemistry and Material Sciences, Springer, 2011, 1-54.
42. Haginaka Y., Sakai Y., Uniform-sized MIP material for (S)-propranolol, J. Pharm. Biomed. Anal., 22, 2000, 899-907.
43. Hosaya K., Frechet J. M. J., Influence of the seed polymer on the chromatographic properties of size monodisperse polymeric separation media prepared by a multi-step swelling and polymerization method, J. Polymer Sci. Polym. Chem. Ed., 31(8), 1993, 2129-2141.
44. Puoci F., Iemma F., Muzzalupo R., Spizzirri U. G., Trombino S., Cassano R., Picci N., Spherical MIPs (SMIPs) via a novel precipitation polymerization in the controlled delivery of sulfasalazine, Macromol. Biosci. 4, 2004, 22-26.
45. Puoci F., Cirillo G., Curcio M., Iemma F., Parisi O. I., Castiglione M., Picci N., MIPs for α-tocopherol delivery, Drug Deliv., 15, 2008a, 253-258.
46. Puoci F., Iemma F., Picci N., Stimuli-responsive MIPs for drug delivery review, Curr. Drug Deliv. 5(2), 2008b, 85-96.
47. Ou S. H., Wu M. C., Chou T. C., Liu C. C., Polyacrylamide gels with electrostatic functional groups for the molecular imprinting of lysozyme, Anal. Chim. Acta, 504, 2004, 163-166.
48. Puoci F., Iemma F., Cirillo G., Picci N., Matricardi P., Alhaique F., MIPs for 5-fluorouracil release in biological fluids, Molecules, 12, 2007, 805-814.
49. Mayes A. G., Mosbach K., MIP beads: suspension polymerization using a liquid perfluorocarbon as the dispersing phase, Anal. Chem., 68, 1996, 3769-3774.
50. Vaihinger D., Landfester K., Kräuter I., Brunner H., Tovar G. E. M., MIP nanospheres as synthetic affinity receptors obtained by miniemulsion polymerization, Macromol. Chem. Phys., 203(13), 2002, 1965-1973.
51. Mayes A. G., Polymerization techniques for the formation of imprinted beads, In: MIPs: Man made mimics of antibodies and their application in analytical chemistry, Sellergren B (ed), Elsevier Science BV, Amsterdam, 2001, 305-322.
52. Liu X. Y., Ding X. B., Guan Y., Peng Y. X., Long X. P., Wang X. C., Chang K., Zhang Y., Fabrication of temperature-sensitive imprinted polymer hydrogel, Macromol. Biosci., 4, 2004, 412-415.
53. Peréz-Moral N., Mayes A. G., Noncovalent imprinting in the shell of core-shell nanoparticles, Langmui, 20, 2004, 3775-3779.
54. Peréz-Moral N., Mayes A. G., Molecularly imprinted multi-layer core-shell nanoparticles-a surface grafting approach, Macromol. Rapid Commun., 28, 2007, 2170-2175.
55. Poma A., Turner, A. P. F., Piletsky S. A., Advances in the manufacture of MIP nanoparticle, Trends in Biotech., 28(12), 2010, 629-637.
56. Zourob M., Mohr S., Fielden P. R., Goddard N. J., A micro-reactor for preparing uniform MIP beads, Lab Chip, 6, 2006, 296-301.
57. Boonpangrak S., Prachayasittikul V., Bülow L., Ye L., MIP microspheres prepared by precipitation polymerization using a sacrificial covalent bond, J. Appl. Pol. Sci., 99(4), 2006, 1390-1398.
58. Wei S., Mizaikoff B., Binding site characteristics of 17β-estradiol imprinted polymers, Biosens. Bioelectron., 23, 2007, 201-209.
59. Yoshimatsu K., Reimhult K., Krozer A., Mosbach K., Sode K., Ye L., Uniform molecularly imprinted microsphere and nanoparticles prepared by precipitation polymerization: The control of particle size suitable for different analytical applications, Anal. Chim. Acta., 58, 2007, 112-121.
60. Kryscio D. R., Peppas N. A. Mimicking biological delivery through feedback-controlled delivery drug release systems based on molecular imprinting. AIChE J. 55, 2009, 1311-1324.
61. Cirillo G., Parisi O. I., Curcio M., Puoci F., Iemma F., Spizzirri U. G., Picci N., MIPs as DDSs for the sustained release of glycyrrhizic acid, Pharm. Pharmaco., 62, 2010, 577-582.
62. Cirillo G., Iemma F., Puoci F., Parisi O. I., Curcio M., Spizzirri U. G., Picci N., Imprinted hydrophilic nanosphere as DDSs for 5-fluorouracil sustained release, J. Drug Target, 17, 2009, 72-77.
63. Venkatesh S., Sizemore S. P., Byrne M. E., Biomimetic hydrogels for enhanced loading and extended release of ocular therapeutics, Biomaterials, 28, 2007, 717-724.
64. Spivak D., Gilmore M. A., Shea J., Evaluation of binding and origins of specificity of 9-ethyladenine imprinted polymers, J. Am. Chem. Soc., 119, 1997, 4388-4393.
65. Deilami S. A., Abdouss M., Khoee S., Synthesis and characterization of MIP for controlled release of tramadol, Cent. Eur. J. Chem., 8(3), 2010, 687-695.
66. Abdouss M., Asadi E., Azodi-Deilami S., Beik-Mohammadi N., Aslanzadeh S. A., Development and characterization of MIPs for controlled release of citalopram, J. Mat. Sci. Mat. Med., 22(10), 2011, 2273-2281.
67. Azodi-Deilami S., Abdouss M., Javanbakht M., The syntheses and characterization of MIPs for the controlled release of bromhexine, Appl. Biochem. Biotech., 164(2), 2010, 1-15.
68. Sole R. D., Lazzoi M. R., Vasapollo G., Synthesis of nicotinamide-based molecularly imprinted microsphere and in vitro controlled release studies, Drug Deliv., 17, 2010, 130-137.
69. Suedee R., Srichana T., Chotivatesin R., Martin G. P., Stereoselective release behaviors of imprinted bead matrices, Drug Dev. Ind. Pharm., 28(5), 2002, 547-556.
70. Alvarez-Lorenzo C., Hiratani H., Gómez-Amoza J. L., Martínez-Pacheco R., Souto C., Conchiero A., Soft contact lenses capable of sustained delivery of timolol, J. Pharm. Sci., 91, 2002, 2182-2192.
71. Alvarez-Lorenzo C., Yañez F., Barreiro-Iglesias R., Concheiro A., Imprinted soft contact lenses as norfloxacin delivery systems, J. Control. Release, 113(3), 2006, 236-244.
72. Hiratani H., Alvarez-Lorenzo C., Timolol uptake and release by imprinted soft contact lenses made of N, N-diethylacrylamide and methacrylic acid, J. Control. Release, 83(2), 2002, 223-230.
73. Javanbakht M., Mohammadi S., Esfangyari-Manesh M., Abdouss M., MIP microspheres with nano-pore cavities prepared by precipitation polymerization as new carriers for the sustained release of dipyridamole, J. Appli. Pol. Sci, 11, 2011, 1586-1593.
74. Suedee R., Bodhibukkana C., Tangthong N., Amnuaikit C., Kaewnopparat S., Srichana T., Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a MIP composite membrane, J. Control. Release, 129(3), 2008, 170-178.
75. Bodhibukkana C., Srichana T., Kaewnopparat S., Tangthong N., Bouking P., Martin G. P., Suedee R., Composite membrane of bacterially-derived cellulose and MIP for use as a transdermal enantioselective controlled-release system of racemic propranolol, J. Control. Release, 113(2-3), 2006, 43-56.
76. Suedee R., Srichana T., Rattananont T., Enantioselective release of controlled delivery granules based on MIPs, Drug Deliv., 9(1), 2002, 19-30.
77. Suedee R., Jantarat C., Lindner W., Viernstein H., Songkro S., Srichana T., Development of a pH-responsive DDSfor enantioselective-controlled delivery of racemic drugs, J. Control. Release, 142(1), 2010, 122-131.
78. Jantarat C., Tangthong N., Songkro S., Martin G. P., Suedee R., S-propranolol imprinted polymer nanoparticle-on-microsphere composite porous cellulose membrane for enantioselectively controlled delivery of racemic propranolol, Int. J. Pharm., 349(1-2), 2008, 212-225.
79. Noss K. R., Vaughan A. D., Byrne M. E., Tailored binding and transport parameters of molecularly imprinted films via macromolecular structure: The rational design of recognitive polymers, J. Appl. Pol. Sci., 107(6), 2008, 3435-3441.
80. Bergmann N. M., Peppas N. A., MIPs with specific recognition for macromolecular and proteins, Prog. Polm. Sci., 33, 2008, 271-288.
81. Bossi A., Bonini F., Turner A. P. F., Piletsky S. A., MIPs for the recognition of proteins: The state of the art, Biosens. Bioelectron., 22, 2007, 1131-1137.
82. Zhou W. H., Lu C. H., Guo X. C., Chen F. R., Yang H. H., Wang X. R., Mussel-inspired MIP coating superparamagnetic nanoparticles for protein recognition, J. Mater. Chem., 20, 2010, 880-883.
83. Bodugoz H., Güven O., Peppas N. A., Glucose recognition capabilities of hydroxyethyl methacrylate-based hydrogels containing poly(ethylene glycol), J. Appli. Pol. Sci., 103, 2007, 432-441.
84. Byrne M. E., Hilt J. Z., Peppas N. A., Recognitive biomemetic networks with moiety imprinting for intelligent drug delivery, J. Biomed. Mater. Res., 84A, 2008, 137-147.
85. Mosbach K., Toward the next generation of molecular imprinting with emphasis on the formation by direct molding, of compounds with biological activity (biomimesis), Anal. Chim. Acta, 435, 2001, 3-8.
86. Kim H-R., Jung J-W., Lee Y-J., Kim J-H., Liquid crystal alignment with a molecular template of imprinted polymer layer during phase separation, Appl. Phy. Letters, 88(11), 2006, 113504-113507.
87. Mujahid A., Stathopulos H., Lieberzeit A. P., Dickert F. L., Solvent vapour detection with cholesteric liquid crystals-optical and mass-sensitive evaluation of the sensor mechanism, Sensors, 10, 2010, 4887-4897.
88. Kan X., Geng Z., Zhao Y., Wang Z., Zhu J-J., Magnetic MIP for aspirin recognition and controlled release, Nanotechnology, 20(16), 2009, 1-7.
89. Chang L., Li Y., Chu J., Qi J., Li X., Preparation of core-shell MIP via the combination of reversible addition-fragmentation chain transfer polymerization and click reaction, 2010, Anal. Chim. Acta, 680, 65-71.
90. Ganta C., Chiyo D., Ayuzawa R., Rachakatla R., Pyle M., Andrews G., Weiss M., Tamura M., Troyer D., Completely abolish rat mammary carcinomas with no evidence of metastasis or recurrence 100 days post-tumor cell inoculation, Cancer Res., 69(5), 2009, 1815-1820.
91. Ozalp V. C., Pedesen T. R., Nielsen L. J., Olsen L. F., Time-resolved measurements of intracellular ATP in the yeast Saccharomyces Cerevisiae using a new type of nanobiosensor, J. Biol. Chem., 285(48), 2010, 37579-37588.
92. Altinoǧlu E. I., Adair J. H., Calcium phosphate nanocomposite particles: a safer and more effective alternative to conventional chemotherapy, Future Oncol., 5(3), 2009, 279-281.
93. Morgan T. T., Muddana H. S., Altiyno L. E., Rouse S. M., Tabakovi A., Tabouillot T., Russin T. J., Shanmugavelandy S. S., Butler P. J., Eklund P. C., Yun J. K., Kester M., Adair J. H., Encapsulation of organic molecules in calcium phosphate nanocomposite particles for intracellular imaging and drug delivery, Nano Lett., 8(12), 2008, 4108-4115.
94. Muddana H. S., Morgan T. T., Adair J. H., Butler P. J., Photophysics of Cy3-encapsulated calcium phosphate nanoparticles, Nano Lett., 9(4), 2009, 1559-1566.
95. Kester M., Heakal Y., Fox T., Sharma A., Robertson G. P., Morgan T. T., Altinolu E., Tabakovi A., Parette M. R., Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells, Nano Lett., 8, 2008, 4116-4121.
96. Jintapatanakit A., Junyaprasert V. B., Kissel T., The role of mucoadhesion of trimethyl chitosan and PEGylated trimethyl chitosan nanocomplexes in insulin uptake, J. Pharm. Sci., 98(12), 2009, 4818-4830.
97. Jintapatanakit A., Mao S., Kissel T., Junyaprasert V. B., Physicochemical properties and biocompatibility of N-trimethyl chitosan: Effect of quaternization and dimethylation, Eur. J. Pharm. Biopharm., 70(2), 2008, 563-571.
98. Thirawong N., Thongborisute J., Takaechi H., Sriamornsak P., Improved intestinal absorption of calcitonin by mucoadhesive delivery of novel pectin-liposome nanocomplexes, J. Control. Release, 125(3), 2008, 236-245.
99. Balivada S., Rachakatla R. S., Wang H., Samarakoon T. N., Dani R. K., Pyle M., Kroh F. O., Walker B., Leaym X., Koper O. B., Tamura M., Chiken V., Bossmann S. H., Troyer DL, A/C magetic hyperthermia of melanoma mediated by iron(0)/iron oxide core/shell magnetic nanoparticles: mouse study, BMC Cancer, 10(1), 2010, 119.
100. Yin J., Cui Y., Yang G., Wang H., Molecularly imprinted nanotubes for enantioselective drug delivery and controlled release, Chem. Commun., 46, 2010, 7688-7690.
101. Spiess K., Lammel A., Scheibel T., Recombinant spider silk proteins for applications in biomaterials, Macromol. Biosci., 10(9), 2010, 998-1007.
102. Ciardelli G., Cioni B., Cristallini C., Barbani N., Silvestri D., Giusti P., Acrylic polymeric nanospheres for the release and recognition of molecules of clinical interest, Biosens. Bioelectron., 20(6), 2004, 1083-1090.
103. Ki C. D., Chang J. Y., Preparation of a MIPic nanocapsule with potential use in delivery applications, Macromolecules, 39(9), 2006, 3415-3419.
104. Hashidzume A., Zimmerman S. C., Switching the selectivity of a polyglycerol dendrimer monomolecularly imprinted with D-(-)-fructose, Tetrahedron Lett., 50(19), 2009, 2204-2207.
105. Wulff G., Chong B-O., Kolb U., Soluble single-molecule nanogels of controlled structure as a matrix for efficient artificial enzymes, Angew. Chem. Int. Ed., 45(12), 2006, 2955-2958.
106. Meziani M. J., Pathak P., Hurezeanu R., Thies M. C., Enick R. M. Sun Y-P., Supercritical-fluid processing technique for nanoscale polymer particles. Angew. Chem. Int. Ed., 43(6), 2004, 704-707.
107. Pathak P. Meziani M. J., Dasai T., Sun Y-P., Nanosizing drug particles in supercritical fluid processing, J. Am. Chem. Soc., 126(35), 2004, 10842-10843.
108. Sane A., Thies M. C., The formation of fluorinated tetraphenylporphyrin nanoparticles via rapid expansion processes: RESSvs RESOLV, J. Phy. Chem., 109, 2005, 19688-19695.
109. Duarte A. R. C., Casimiro T., Aguiar-Rcardo A., Simplicio A. L., Duarte C. M. M., Supercritical fluid polymerization and impregnation of MIPs for drug delivery, J. Supercrit. Fluids, 39(1), 2006, 102-106.
110. Motornov M., Roiter Y., Tokarev I., Minko S., Stimuli-responsive nanoparticles, nanogels and capsules for integratedmultifunctional intelligent systems, Progr. Polm. Sci., 35, 2010, 174-211.
111. Gültekin A., Ersöz A., Hür D., Sariözlü N. Y., Denizli A., Say R., Gold nanoparticles having dipicolinic acid imprinted nanoshell for Bacillus cereus spores recognition, Appl. Surface Sci., 256(1), 2009, 142-148.
112. Graf P., Mantion A., Foelske A., Shkilny A., Mašić A., Thünemann A. F., Taubert A., Peptide-coated silver nanoparticles: Synthesis, surface chemistry, and pH-triggered, reversible assembly into particle assemblies, Chemistry, 15(23), 2009, 5831-5844.
113. Petersen A., Barchanski A., Taylor U., Klein S., Rath D., Barcikowski S., Penetratin-conjugated gold nanoparticles - Design of cell-penetrating nanomarkers by femtosecond laser ablation, J. Phys. Chem. C, 115(12), 2011, 5152-5159.
114. Tauer K., Weber N., Texter J., Core-shell reversible particle precipitation from aqueous di-stimuli-responsive diblocks, Chem. Comm., 2009, 1-8.
115. Maier N. M., Lindner W., Chiral application applications of MIPs: a critical review, Anal. Bioanal. Chem., 389, 2007, 377-397.
116. Andersson L. I., Müller R., Vlatakis G., Mosbach K., Mimics of the binding sites of opioid receptors obtained by molecular imprinting of enkephalin and morphine, Proc. Natl. Acad. Sci. USA, 92, 1995, 4788-4792.
117. Hoshino Y., Koide H., Urakami T., Kanazawa H., Kodama T., Oku N., Shea K. J., Peptide imprinted polymer nanoparticles: a plastic antibody, J. Am. Chem. Soc., 132(19), 2010, 6644-6645.
118. Ramström O., Ye L., Mosbach K., Artificial antibodies to corticosteroids prepared by molecular imprinting, Chem. Biol., 3(6), 1996, 471-477.
119. Ye L., Mosbach K., Molecular imprinting: synthetic materials as substitutes for biological antibodies and receptors, Chem. Mater., 20, 2008, 859-868.
120. Petros R. A., DeSimone J. M., Strategies in the design of nanoparticles for therapeutic applications, Nature Rev. Drug Discovery, 9, 2010, 615-627.
121. Dickert F. L., Hayden O., Bindeus R., Mann K-J., Blass D., Waigmann E., Bioimprinted QCM sensors for virus detection-screening of plant sap, Anal. Bioanal. Chem., 378, 2004, 1929-1934.
122. Schihagl R., Lieberzeit P. A., Dickert F. L., Chemosensors for viruses based on artificial immunoglobulin copies, Advanced Materials, 2010, 22, 2078-2081.
123. Hoshino Y., Kodama T., Okahata Y., Shea K. J., Peptide imprinted polymer nanoparticles: a plastic antibody, J. Am. Chem. Soc., 130, 2008, 6644-6645.